LD
GILD icon

Lipe & Dalton’s Gilead Sciences GILD Stock Holding History

Lipe & Dalton’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-43,335
Closed -$3.33M – 97
2020
Q2 		$3.33M Sell
43,335
-4,150
-9% -$318K 2.42% 16
2020
Q1 		$3.55M Sell
47,485
-4,650
-9% -$321K 3% 9
2019
Q4 		$3.39M Sell
52,135
-2,487
-5% -$162K 2.25% 17
2019
Q3 		$3.46M Sell
54,622
-2,079
-4% -$136K 2.53% 14
2019
Q2 		$3.83M Sell
56,701
-53
-0.1% -$3.49K 2.74% 14
2019
Q1 		$3.69M Sell
56,754
-774
-1% -$51.4K 2.71% 14
2018
Q4 		$3.6M Sell
57,528
-5,499
-9% -$384K 2.93% 13
2018
Q3 		$4.87M Buy
63,027
+1,501
+2% +$113K 3.32% 9
2018
Q2 		$4.36M Buy
61,526
+10,966
+22% +$774K 3.21% 9
2018
Q1 		$3.81M Buy
50,560
+1,135
+2% +$90.2K 2.73% 16
2017
Q4 		$3.54M Sell
49,425
-1,105
-2% -$83.9K 2.45% 22
2017
Q3 		$4.09M Buy
50,530
+340
+0.7% +$26K 2.88% 13
2017
Q2 		$3.55M Buy
50,190
+11,575
+30% +$770K 2.3% 18
2017
Q1 		$2.62M Buy
38,615
+2,360
+7% +$166K 1.9% 26
2016
Q4 		$2.6M Sell
36,255
-2,470
-6% -$184K 1.85% 26
2016
Q3 		$3.06M Buy
38,725
+9,675
+33% +$786K 2.05% 24
2016
Q2 		$2.42M Buy
29,050
+1,440
+5% +$128K 1.67% 26
2016
Q1 		$2.54M Buy
27,610
+5,570
+25% +$502K 1.99% 23
2015
Q4 		$2.23M Buy
+22,040
New +$2.29M 1.81% 24

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Lipe & Dalton's GILD Position: Q3 2020 in Review

Lipe & Dalton sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 43,335 shares — an estimated $3.33M sold.

Lipe & Dalton first reported a position in GILD in Q4 2015 and held it in 19 quarters. The position peaked at $4.87M in Q3 2018. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Lipe & Dalton reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • Lipe & Dalton sold 43,335 Gilead Sciences shares in Q3 2020, an estimated $3.33M.
  • Lipe & Dalton first reported a position in Gilead Sciences in Q4 2015 and held it in 19 quarters.
  • Lipe & Dalton's Gilead Sciences position peaked at $4.87M in Q3 2018.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Lipe & Dalton's 13F filing for Q3 2020, filed 30 Oct 2020.